1. Home
  2. AMC vs HRMY Comparison

AMC vs HRMY Comparison

Compare AMC & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AMC Entertainment Holdings Inc.

AMC

AMC Entertainment Holdings Inc.

HOLD

Current Price

$2.60

Market Cap

2.4B

ML Signal

HOLD

Logo Harmony Biosciences Holdings Inc.

HRMY

Harmony Biosciences Holdings Inc.

N/A

Current Price

$42.14

Market Cap

2.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AMC
HRMY
Founded
1920
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Movies/Entertainment
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
2.2B
IPO Year
2007
2020

Fundamental Metrics

Financial Performance
Metric
AMC
HRMY
Price
$2.60
$42.14
Analyst Decision
Hold
Buy
Analyst Count
4
9
Target Price
$2.03
$44.11
AVG Volume (30 Days)
18.1M
679.4K
Earning Date
05-05-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
7.97
EPS
N/A
1.84
Revenue
$4,848,900,000.00
$868,453,000.00
Revenue This Year
$11.41
$19.75
Revenue Next Year
$5.18
$12.88
P/E Ratio
N/A
$22.42
Revenue Growth
4.57
21.51
52 Week Low
$0.93
$25.52
52 Week High
$3.18
$41.49

Technical Indicators

Market Signals
Indicator
AMC
HRMY
Relative Strength Index (RSI) 54.02 67.49
Support Level $2.32 $37.30
Resistance Level $3.00 N/A
Average True Range (ATR) 0.14 1.11
MACD -0.01 0.16
Stochastic Oscillator 61.41 100.00

Price Performance

Historical Comparison
AMC
HRMY

About AMC AMC Entertainment Holdings Inc.

AMC Entertainment Holdings Inc is involved in the theatrical exhibition business. The company owns, operates, or has interests in theatres located in the United States and Europe. It provides amenities such as plush, power recliners, MacGuffins full bars, AMC Dine-In Theatres, and premium presentation. The company has identified two reportable segments and reporting units for its theatrical exhibition operations, U.S. markets and International markets. It derives key revenue from the U.S.

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company has one reportable segment: rare neurological diseases. Its product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

Share on Social Networks: